Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review [PDF]
Mark T. Reding +11 more
openalex +1 more source
Preclinical Evaluation of the Systemic Safety, Efficacy, and Biodistribution of a Recombinant AAV8 Vector Expressing FIX-TripleL in Hemophilia B Mice: Implications for Human Gene Therapy. [PDF]
Chou SC +11 more
europepmc +1 more source
Retrospective analysis of hemophilia B in Turkey: identifying main characteristics and treatment options. [PDF]
Zülfikar B +41 more
europepmc +1 more source
Lentiviral-Engineered Mesenchymal Stem Cells for Hemophilia B Gene Therapy
Megan Dodd
openalex +1 more source
[Gene therapy marks the beginning of a potential "clinical cure" for hemophilia B patients]. [PDF]
Zhang L.
europepmc +1 more source
AAV vectors for long-term gene therapy of hemophilia B: Are we there yet? [PDF]
Srivastava A.
europepmc +1 more source
A Case of Epidural Hematoma after Lumbar Spine Surgery in a Hemophilia B Carrier. [PDF]
Sakamoto Y +4 more
europepmc +1 more source
Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B. [PDF]
Gao M +14 more
europepmc +1 more source

